SRPT - Sarepta Therapeutics, Inc.
IEX Last Trade
123.69
0.875 0.707%
Share volume: 10,304
Last Updated: Thu 26 Dec 2024 08:30:07 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$122.82
0.88
0.71%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-02 | 2022-11-02 | 2023-02-28 | 2023-05-02 | 2023-08-02 | 2023-11-01 | 2024-02-28 | 2024-05-01 | |
| Total revenue | 233.487 M | 230.269 M | 258.427 M | 253.500 M | 261.238 M | 331.817 M | 396.781 M | 413.464 M | |
| Cost of revenue | 37.795 M | 39.952 M | 30.799 M | 35.017 M | 34.124 M | 37.026 M | 44.176 M | 50.559 M | |
| Gross profit | 195.692 M | 190.317 M | 227.628 M | 218.483 M | 227.114 M | 294.791 M | 352.605 M | 362.905 M | |
| -2.75% | 19.60% | -4.02% | 3.95% | 29.80% | 19.61% | 2.92% | |||
| Operating expenses | 406.645 M | 321.494 M | 334.282 M | 356.393 M | 360.454 M | 315.194 M | 327.217 M | 327.399 M | |
| Selling general and admin | 154.316 M | 104.787 M | 120.478 M | 110.714 M | 118.564 M | 120.893 M | 131.700 M | 127.003 M | |
| Research and development | 252.329 M | 216.707 M | 213.804 M | 245.679 M | 241.890 M | 194.301 M | 195.517 M | 200.396 M | |
| Total expenses | 444.619 M | 361.624 M | 365.260 M | 391.588 M | 394.757 M | 352.659 M | 372.156 M | 378.559 M | |
| -18.67% | 1.01% | 7.21% | 0.81% | -10.66% | 5.53% | 1.72% | |||
| Operating income | -211.132 M | -131.355 M | -106.833 M | -138.088 M | -133.519 M | -20.842 M | 24.625 M | 34.905 M | |
| Ebit | -211.132 M | -131.355 M | -106.833 M | -138.088 M | -133.519 M | -20.842 M | 24.625 M | 34.905 M | |
| Pretax income | -228.093 M | -256.418 M | -101.306 M | -512.710 M | -14.585 M | -33.174 M | 40.371 M | 41.448 M | |
| 12.42% | -60.49% | 406.10% | -97.16% | 127.45% | -221.69% | 2.67% | |||
| Income tax | 3.388 M | 1.320 M | 7.938 M | 4.045 M | 9.355 M | 7.763 M | -5.284 M | 5.329 M | |
| Net income basic | -231.481 M | -257.738 M | -109.244 M | -516.755 M | -23.940 M | -40.937 M | 45.655 M | 36.119 M | |
| -11.34% | 57.61% | -373.03% | 95.37% | -71.00% | 211.53% | -20.89% | |||
| Net income | -231.481 M | -257.738 M | -109.244 M | -516.755 M | -23.940 M | -40.937 M | 45.655 M | 36.119 M | |
| -11.34% | 57.61% | -373.03% | 95.37% | -71.00% | 211.53% | -20.89% |